Tuberculosis research: Quo vadis.

Drug Target Insights

The Foundation for Medical Research, Dr. Kantilal J. Sheth Memorial Building, Mumbai - India.

Published: May 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149609PMC
http://dx.doi.org/10.33393/dti.2024.3076DOI Listing

Publication Analysis

Top Keywords

tuberculosis quo
4
quo vadis
4
tuberculosis
1
vadis
1

Similar Publications

Eradication of bovine tuberculosis in Ireland: is it a case of now or never?

Ir Vet J

December 2024

Centre for Veterinary Epidemiology and Risk Analysis, School of Veterinary Medicine, UCD, University College Dublin, Belfield, Dublin, D04 W6F6, Ireland.

There has been a sharp disimprovement in the bovine tuberculosis (bTB) situation in Ireland in recent years. This commentary argues for critical programme change in three overarching themes relevant to the Irish bTB eradication programme, if eradication is to be successful: (1) Limiting infection in cattle. Residual (hidden) infection is an important constraint to eradication, due to the use of imperfect diagnostic tests.

View Article and Find Full Text PDF

Background: The prevention and control of infectious disease outbreaks in carceral settings face unique challenges. Transmission modeling is a powerful tool for understanding and addressing these challenges, but reviews of modeling work in this context pre-date the proliferation of outbreaks in jails and prisons during the SARS-CoV-2 pandemic. We conducted a systematic review of studies using transmission models of respiratory infections in carceral settings before and during the pandemic.

View Article and Find Full Text PDF

Dynamic modelling of improved diagnostic testing for drug-resistant tuberculosis in high burden settings.

BMC Infect Dis

November 2024

Program in Health Services and Systems Research, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.

Background: Limited diagnostic testing for drug-resistant TB (DR-TB) may lead to high rates of misdiagnosis and undertreatment. Current diagnostic tests focus only on detection of rifampicin-resistant TB (RR-TB). This study aims to determine the impact of improved diagnostic testing for a wider range of drug resistance on DR-TB outcomes in high-burden TB settings, using the Philippines and Thailand as case studies.

View Article and Find Full Text PDF

Background: The eastern European and central Asian (EECA) region has the fastest growing HIV epidemic globally. We aimed to identify how HIV resources could be allocated for maximum health impact.

Methods: Between Aug 1 and Dec 23, 2022, allocative efficiency analyses were undertaken for 12 countries in the EECA region (Albania, Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kosovo, Kyrgyzstan, Moldova, Serbia, Tajikistan, and Uzbekistan) using HIV epidemic models developed with Optima HIV.

View Article and Find Full Text PDF

Tuberculosis research: Quo vadis.

Drug Target Insights

May 2024

The Foundation for Medical Research, Dr. Kantilal J. Sheth Memorial Building, Mumbai - India.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!